Asthma is more common in females from puberty onward, affecting 9.6% of adult women compared to 6.3% of adult men. Women are also three times more likely to be hospitalized for an asthma-related event. But this wasn’t always the case for them individually: as children, boys actually have higher asthma rates than girls (11.9% vs. 7.5%). Something changes during adolescence that flips the pattern, and it stays flipped for the rest of life.
The reasons involve a combination of hormonal shifts, differences in airway anatomy, immune system behavior, and environmental exposures that disproportionately affect women.
The Puberty Crossover
The shift from male-dominant to female-dominant asthma tracks almost exactly with puberty. Around age 10, as girls begin developing (measured by physical maturity markers called Tanner stages), their average asthma symptom scores rise while boys’ scores decline. By mid-adolescence, girls have overtaken boys in both prevalence and severity, and this gap persists through adulthood.
This timing is the strongest single piece of evidence that sex hormones play a central role. It’s not a gradual drift. It’s a crossover that maps onto the biological changes of puberty in both directions: rising estrogen and progesterone in girls, rising testosterone in boys.
What Testosterone Does for the Lungs
Testosterone appears to actively protect against a specific type of airway inflammation. The immune system contains a group of cells called ILC2s that drive the kind of allergic, inflammatory response behind most asthma. These cells carry receptors for testosterone, and when testosterone binds to them, it directly suppresses their ability to multiply and mature. In lab studies, adding testosterone to developing ILC2 cells inhibited their growth over a 10-day period, while blocking testosterone’s receptor reversed that protection.
This isn’t just a minor effect. Research using mixed immune-system models showed that the testosterone receptor on ILC2 cells themselves, not on surrounding tissue, is the main pathway creating sex differences in allergic lung inflammation. In other words, testosterone doesn’t just reduce inflammation generally. It specifically puts the brakes on the immune cells most responsible for asthma-type reactions. As boys go through puberty and testosterone levels climb, this protective effect kicks in. Girls don’t get that benefit.
Estrogen’s Complicated Role
Estrogen’s relationship with asthma is less straightforward than testosterone’s. At the cellular level, estrogen can actually relax airway muscles. It triggers a signaling pathway that lowers calcium inside smooth muscle cells, which loosens them and opens the airways, similar to how a rescue inhaler works. Estrogen even amplifies the effect of the compounds in those inhalers.
So why doesn’t this protect women? Because estrogen also stimulates parts of the immune system that drive inflammation. Female mice consistently show higher levels of key inflammatory signals (IL-4 and IL-5) in lung tissue during allergic challenges. The net result seems to be that estrogen’s pro-inflammatory effects on the immune system outweigh its muscle-relaxing benefits, tipping the balance toward more frequent and more severe asthma in women.
The clearest evidence comes from hormone replacement therapy after menopause. In a large French cohort study, women using estrogen-only hormone therapy had a 54% higher risk of developing new-onset asthma compared to women who never used hormones. Among never-smokers, that risk jumped to 80% higher. Women with a history of allergies who took estrogen-only therapy faced an 86% increased risk.
Smaller Airways, Same Lung Size
Women’s central airways are physically smaller than men’s, even after accounting for differences in overall lung size. CT imaging studies show that when men and women are matched for total lung capacity, women’s tracheas are about 19.5% smaller in cross-sectional area. The main bronchi (the two large tubes branching off the trachea) are 18 to 24% smaller. One intermediate airway measured 25% smaller in women.
This size difference is concentrated in the larger, central airways. Once you get deeper into the lungs, the smaller branches are roughly the same size in both sexes. The practical consequence is that women start with narrower “main highways” for air. Any degree of swelling or mucus buildup that narrows those airways will have a proportionally larger effect on airflow, making the same level of inflammation feel worse and become dangerous faster.
Menstrual Cycle Effects
Nearly 44% of women with asthma report that their symptoms worsen in the days before their period. This pattern, sometimes called perimenstrual asthma, coincides with the steep drop in both estrogen and progesterone that triggers menstruation. The hormonal fluctuation itself appears to be the problem, not a sustained high or low level. Women with perimenstrual asthma often find that their usual medications are less effective during this window, making it a predictable but frustrating part of managing the condition.
Obesity Hits Women’s Asthma Harder
Obesity is a risk factor for asthma in both sexes, but the connection is stronger in women. Fat tissue produces a hormone called leptin, which promotes inflammation throughout the body, including in the airways. Meta-analyses consistently find significantly elevated leptin levels in people with asthma who are also obese, and this inflammatory pathway operates independently of the allergic mechanisms behind typical asthma. Because women naturally carry a higher percentage of body fat and produce more leptin at any given weight, the obesity-asthma link creates a disproportionate burden. This “obese asthma” phenotype tends to develop in adulthood, responds poorly to standard asthma medications, and is more common in women than men.
Cleaning Products and Occupational Exposure
Women are significantly more likely to be exposed to cleaning chemicals both at work and at home. In studies of women with asthma, occupational exposure to detergents and disinfectants was associated with a 2.8 times higher odds of symptomatic asthma and a 5.1 times higher odds of severe asthma. These associations held up even in women who didn’t have positive allergy skin tests and who had low levels of allergic antibodies and eosinophils, the markers you’d expect in classic allergic asthma. This points to a non-allergic irritant mechanism: the chemicals directly damage and inflame airway tissue rather than triggering an immune overreaction.
Cleaning-related asthma is one of the most modifiable risk factors in this entire picture. Women in professional cleaning roles, healthcare, and domestic work face the highest exposures, and the effect compounds over years of regular contact with sprays, bleach, and ammonia-based products.
Why the Gap Matters
The sex disparity in asthma isn’t just about who gets diagnosed. Women experience more severe disease, more hospitalizations, and more difficulty achieving symptom control. The combination of narrower central airways, stronger inflammatory immune responses, monthly hormonal fluctuations, and greater environmental exposures creates a layered vulnerability that no single factor explains on its own. Each one adds a modest increase in risk, but together they produce the striking three-to-one hospitalization ratio seen in adult women compared to men.